Last reviewed · How we verify
NCT03305614
TDCS and Aphasia Therapy in the Chronic Phase After Stroke
Phase 2 trial testing tDCS in Aphasia Following Cerebral Infarction in 25 participants. Terminated before completion.
18 April 2018
Quick facts
| Lead sponsor | University Hospital, Ghent |
|---|---|
| Phase | Phase 2 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 24 November 2017 |
| Primary completion | 18 April 2018 |
| Estimated completion | 18 April 2018 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- tDCS — full drug profile →
- Aphasia therapy
Conditions studied
- Aphasia Following Cerebral Infarction — all drugs for Aphasia Following Cerebral Infarction →
- Aphasia Following Nontraumatic Intracerebral Hemorrhage — all drugs for Aphasia Following Nontraumatic Intracerebral Hemorrhage →
Sponsor
University Hospital, Ghent
Who can join
Adults 18 to 85, any sex, with Aphasia Following Cerebral Infarction or Aphasia Following Nontraumatic Intracerebral Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the neuromodulatory effect of combined tDCS and aphasia therapy in patients in the chronic phase after stroke. Half of the participants will receive aphasia therapy and tDCS, the other half will receive aphasia therapy and sham-tDCS.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke.
Elsner B, Kugler J, Pohl M, Mehrholz J. · · 2019 · cited 62× · PMID 31111960 · DOI 10.1002/14651858.cd009760.pub4
Verify or expand the search:
- PubMed search for NCT03305614
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of tDCS
Trials testing the same drug.
- NCT07400939 — Brain Stimulation Combined With Watching Hand Movements to Improve Hand Recovery in Chronic Stroke · NA · recruiting
- NCT06994390 — Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial) · NA · not yet recruiting
- NCT07358832 — Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease · NA · recruiting
- NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
- NCT06972368 — Home-Based tDCS for Depression in BPD · NA · recruiting
Other recruiting trials for Aphasia Following Cerebral Infarction
Currently open trials in the same condition.
- NCT07281313 — Aphasia Physical EXercise Study: Randomized Trial · NA · recruiting
- NCT06842745 — Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia · Phase 2 · recruiting
- NCT06968663 — Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia · Phase 2 · recruiting
Other University Hospital, Ghent trials
Trials by the same sponsor.
- NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
- NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
- NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03305614 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03305614.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing